|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date04 Jun 2021 |
100 Clinical Results associated with Emergent BioDefense Operations Lansing, Inc.
0 Patents (Medical) associated with Emergent BioDefense Operations Lansing, Inc.
100 Deals associated with Emergent BioDefense Operations Lansing, Inc.
100 Translational Medicine associated with Emergent BioDefense Operations Lansing, Inc.